| Umbricht, Christopher B |
Johns Hopkins University
United States |
Discovery and validation of early molecular breast cancer risk markers in benign breast disease |
5R01CA222779-06 |
|
Sidney Fu, M.D. |
| Ulrich, Cornelia M |
University Of Utah
United States |
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link |
5R01CA254108-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Asad Umar, D.V.M., Ph.D. |
| Tussing-Humphreys, Lisa |
University Of Illinois At Chicago
United States |
Mediating Role of Gut Microbiota in the Regulation of Colorectal Cancer Risk in the Context of Time-restricted Eating and Calorie Restriction |
3R01CA257807-03S1 |
RFA-CA-20-004 (R01 Clinical Trial Optional) |
Sharon Ross, Ph.D., M.P.H. |
| Turesky, Robert J. |
University Of Minnesota
United States |
DNA adductomics of the urinary system |
5R01CA220367-06 |
|
Wendy Wang, Ph.D., M.Sc. |
| Torres, Keila Enitt |
University Of Tx Md Anderson Can Ctr
United States |
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
1R01CA285980-01 |
|
Richard Mazurchuk, Ph.D. |
| Toriola, Adetunji T |
Washington University
United States |
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention |
5R37CA235602-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Tollefsbol, Trygve O |
University Of Alabama At Birmingham
United States |
Combinatorial epigenetic-based prevention of breast cancer |
5R01CA178441-09 |
|
Gabriela Riscuta, M.D., C.N.S. |
| Tighiouart, Mourad |
Cedars-Sinai Medical Center
United States |
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials |
3U01CA232859-05S1 |
|
Rachel Altshuler, Ph.D. |
| Thompson, Patricia Ann |
State University New York Stony Brook
United States |
Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk |
5R01CA235720-05 |
|
Edward Sauter, M.D., Ph.D. |
| Thomas, Christoforos |
Methodist Hospital Research Institute
United States |
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome |
5R21CA267386-03 |
PAR-20-292 (R21 Clinical Trial Optional) |
Winfred Malone, Ph.D., M.P.H. |